Genetic Risk and Outcome of Psychosis (GROUP), A multi site longitudinal cohort study focused on gene-environment interaction: Objectives, sample characteristics, recruitment and assessment methods

International Journal of Methods in Psychiatric Research

Volumn 21, Issue 3, 2012, Pages 205-221

  Korver, Nikie ^a   Quee, Piotr J ^b   Boos, Heleen B M ^c   Simons, Claudia J P ^d   De Haan, Lieuwe ^a   Kahn, Rene S ^d   Linszen, Don H ^d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aetiology; Environment; Gene; Interaction; Longitudinal; Methodology; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RISK; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARD; TIME;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE-ENVIRONMENT INTERACTION; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; RESEARCH DESIGN; RISK; SCHIZOPHRENIA; TIME FACTORS; YOUNG ADULT;

EID: 84865992808     PISSN: 10498931     EISSN: 15570657     Source Type: Journal    
DOI: 10.1002/mpr.1352     Document Type: Article

References (92)

1. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. (1993) Assessment of insight in psychosis. The American Journal of Psychiatry, 150(6), 873-879.
2. APA (2000) Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV-TR), Washington, DC: American Psychiatric Association.
3. Andreasen N.C. (1984a) Scale for the Assessment of Positive Symptoms (SAPS), Iowa City, IA, University of Iowa.
4. Andreasen N.C. (1984b) Modified Scale for the Assessment of Negative Symptoms (SANS), Iowa City, IA, University of Iowa.
5. Andreasen N.C., Flaum M., Arndt S. (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry, 49(8), 615-623.
6. Andresen R., Caputi P., Oades L.G. (2000) Interrater reliability of the Camberwell assessment of need short appraisal schedule. Austalian and New Zealand Journal of Psychiatry, 34(5), 856-861.
7. Andrews G., Peters L. (1998) The psychometric properties of the Composite International Diagnostic Interview. Social Psychiatry and Psychiatric Epidemiology, 33(2), 80-88.
8. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T.E. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BioMed Central, 325(7374), 1183-1184.
9. Baas D., van 't Wout M., Aleman A., Kahn R.S. (2008) Social judgement in clinically stable patients with schizophrenia and healthy relatives: behavioural evidence of social brain dysfunction. Psychological Medicine, 38, 747-754.
10. Barnes T.R. (1989) A rating scale for drug-induced akathisia. The British Journal of Psychiatry, 154, 672-676.
11. Baskak B., Ozel E.T., Atbasoglu E.C., Baskak S.C. (2008) Peculiar word use as a possible trait marker in schizophrenia. Schizophrenia Research, 103(1-3), 311-317.
12. Benton A.L., Sivan A.B., de Hamsher K.S., Varney N.R., Spreen O. (1983) Benton's Test of Facial Recognition, New York: Oxford University Press.
13. Bilder R.M., Turkel E., Lipschutz-Broch L., Lieberman J.A. (1992) Antipsychotic medication effects on neuropsychological functions. Psychopharmacology Bulletin, 28(4), 353-366.
14. Boyette L.N.J., Swets M., Meijer C.J., Wouters L., Genetic Risk and Outcome of Psychosis (GROUP). (2011) Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms. Psychiatry Research, 30(186), 409-413.
15. Brand N., Jolles J. (1985) Learning and retrieval rate of words presented auditorily and visually. The Journal of General Psychology, 112(2), 201-210.
16. Brugha T.S., Nienhuis F.J., Bagchi D., Smith J., Meltzer H. (1999) The survey form of SCAN: the feasibility of using experienced lay survey interviewers to administer a semi-structured systematic clinical assessment of psychotic and non psychotic disorders. Psychological Medicine, 29(3), 703-712.
17. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophrenia Bulletin, 8(3): 470-484.
18. Corcoran R., Mercer G., Frith C.D. (1995) Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia. Schizophrenia Research, 17(1), 5-13.
19. Cottler L.B., Robins L.N., Helzer J.E. (1989) The reliability of the CIDI-SAM: a comprehensive substance abuse interview. British Journal of Addiction, 84(7), 801-814.
20. De Haan L., Hoogenboom B., Beuk N., Wouters L., Dingemans P.H., Linszen D.Z. (2006) Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients. Psychopharmacology Bulletin, 39(1), 25-30.
21. Derks E.M., Verweij K.H., Kahn R.S., Cahn W.C. (2009) The calculation of familial loading in schizophrenia. Schizophrenia Research, 111(1-3), 198-199.
22. El-Missiry A., Aboraya A.S., Manseur H., Manchester J., France C., Border K. (2011) An update on the epidemiology of schizophrenia with a special reference to clinically important risk factors. International Journal of Mental Health and Addition, 9(1): 39-59.
23. European Network of Schizophrenia Networks for the Study of Gene-Environment Interactions (EU-GEI). (2008) Schizophrenia aetiology: Do gene-environment interactions hold the key? Schizophrenia Research, 102(1-3), 21-26.
24. Fanous A., Gardner C., Walsh D., Kendler K.S. (2001) Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Archives of General Psychiatry, 58(7): 669-673.
25. Franken I.H., Hendriksa V.M., van den Brink W. (2002) Initial validation of two opiate craving questionnaires the obsessive compulsive drug use scale and the desires for drug questionnaire. Addictive Behaviors, 27(5), 675-685.
26. Gervais H., Belin P., Boddaert N., Leboyer M., Coez A., Sfaello I., Barthelemy C., Brunelle F., Samson Y., Zilbovicius M. (2004) Abnormal cortical voice processing in autism. Nature Neuroscience, 7(8): 801-802.
27. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. (1989a) The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 46(11): 1006-1011.
28. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. (1989b) The Yale-Brown Obsessive Compulsive Scale II: validity. Archives of General Psychiatry, 46(11): 1012-1016.
29. Gottesman I.I., Gould T.D. (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. The American Journal of Psychiatry, 160(4), 636-645.
30. Gur R.E., Calkins M.E., Gur R.C., Horan P.H., Nuechterlein K.H., Seidman L.J., Stone W.S. (2007) The consortium on the genetics of schizophrenia: neurocognitive endophenotypes. Schizophrenia Bulletin, 33(1), 49-68.
31. Guy W.A. (1976) Abnormal Involuntary Movement Scale (AIMS). In EDCEU Assessment Manual for Psychopharmacology, Guy W.A. (ed), pp. 534-537, Washington, DC: Department of Health Education and Welfare.
32. Hanssen M., Krabbendam L., Vollema M., Delespaul P., van Os J. (2006) Evidence for instrument and family specific variation of subclinical psychosis dimensions in the general population. Journal of Abnormal Psychology, 115(1): 5-14.
33. Hanssen M., Peeters F., Krabbendam L., Radstake S., Verdoux H., Van Os J. (2003) How psychotic are individuals with non-psychotic disorders? Social Psychiatry and Psychiatric Epidemiology, 38(3), 149-154.
34. Haro J.M., Kamath S.A., Ochoa D., Rele K., Fargas A., Rodrigues M.J., Rele R., Orta J., Kharbeng A., Araya S., Gervin M., Alonso J., Mavreas V., Lavrentzou E., Liontos N., Gregor K., Jones P.B., SOHO Study Group. (2003) The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica, 107(Suppl. 416): 16-23.
35. Harrison P.J., Weinberger D.R. (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry, 10(1), 40-68.
36. Hirvonen J., van Erp T.G., Huttunen J., Aalto S., Nagren K., Huttunen M., Lonnqvist J., Kaprio J., Hietala J., Cannon T.D. (2005) Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Archives of General Psychiatry, 62(4): 371-378.
37. Horan W.P., Braff D.L., Nuechterlein K.H., Sugar C.A., Cadenhead K.S., Calkins M.E., Dobie D.J., Freedman R., Greenwood T.A., Gur R.E., Gur R.C., Light G.A., Mintz J., Olincy A., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Green M.F. (2008) Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research, 103(1-3): 218-228.
38. Huttunen J., Heinimaa M., Svirskis T., Nyman M., Kajander J., Forsback S., Solin O., Ilonen T., Korkeila J., Ristkari T., McGlashan T., Salokangas R.K., Hietala J. (2008) Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biological Psychiatry, 63(1): 114-117.
39. Janssen B., Gaebel W., Haerter M., Komaharadi F., Lindel B., Weinmann S. (2006) Evaluation of factors influencing medication compliance in inpatient treatment of psychotic disorders. Psychopharmacology, 187(2), 229-236.
40. Janssen I., Krabbendam L., Jolles J., van Os J. (2003) Alterations in theory of mind in patients with schizophrenia and non-psychotic relatives. Acta Psychiatrica Scandinavica, 108(2): 110-117.
41. Kapur S. (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. The American Journal of Psychiatry, 160(1), 13-23.
42. Kay S.R., Fiszbein A., Opler L.A. (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261-276.
43. Kelly B.D., O'Callaghan E., Waddington J.L., Feeney L., Browne S., Scully P.J., Clarke M., Quinn J.F., McTigue O., Morgan M.G., Kinsella A., Larkin C. (2010) Schizophrenia and the city: a review of literature and perspective study of psychosis and urbanicity in Ireland. Schizophrenia Research, 116(1): 75-89.
44. Kendler K.S., Hewitt J. (1992) The structure of self-report schizotypy in twins. Journal of Personality Disorders, 6(1): 1-17.
45. Kendler K.S., Lieberman J.A., Walsh D. (1989) The Structured Interview for Schizotypy (SIS): a preliminary report. Schizophrenia Bulletin, 15(4), 559-571.
46. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., Walsh D. (1993) The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Archives of General Psychiatry, 50(10): 781-788.
47. Khoury M.J., Flandres W.D. (1996) Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! American Journal of Epidemiology, 37(1), 1-6.
48. Kim S.W., Dysken M.W., Kuskowski M. (1990) The Yale-Brown Obsessive-Compulsive Scale: a reliability and validity study. Psychiatry Research, 34(1): 99-106.
49. Kirkpatrick B., Buchanan R.W., McKenney P.D., Alphs L.D., Carpenter W.T. Jr (1989) The schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Research, 30(2): 119-123.
50. Konings M., Bak M., Hanssen M., van Os J., Krabbendam L. (2006) Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatrica Scandinavica, 114(1), 55-61.
51. Krabbendam L., Marcelis M., Delespaul P., Jolles J., van Os J. (2001) Single or multiple familial cognitive risk factors in schizophrenia? American Journal of Medical Genetics, 105(2), 183-188.
52. Leucht S., Kane J.M., Etschel E., Kissling W., Hamann J., Engel R.R. (2006) Linking the PANSS, BPRS, and CGI: clinical implications. Neuropharmacology, 31(10): 2318-2325.
53. Martinez-Martin P., Gil-Nagel A., Gracia L.M., Gomez J.B., Martinez-Sarries J., Bermejo F. (1994) Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Movement Disorders, 9(1): 76-83.
54. Maxwell M.E. (1992) Manual for the FIGS (Family Interview for Genetic Studies), Bethesda, MD, Clinical Neurogenetics Branch, National Institute of Mental Health, Intramural Research Program.
55. McGrath J., Saha S., Welham J., El Saadi O., MacCauley C., Chant D. (2004) A systematic review of the incidence of schizophrenia: the distrivution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine, 2, 13.
56. Menezes N.M., Arenovich T., Zipursky R.B. (2006) A systematic review of longitudinal outcome studies of first-episode psychosis. Psychological Medicine, 36(10), 1349-1362.
57. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370(9584): 319-328.
58. Morgan C., Charalambides M., Hutchinson G., Murray R.M. (2010) Migration, ethnicity, and psychosis: toward a social developmental model. Schizophrenia Bulletin, 36(4), 655-664.
59. Musshoff F., Madea B. (2006) Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Therapeutic Drug Monitoring, 28(2): 155-163.
60. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. (2004) Identification of separable cognitive factors in schizophrenia. Schizophrenia Research, 72(1): 29-39.
61. Nuechterlein K.H.R., Dawson M.E. (1984) Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophrenia Bulletin, 10, 160-203.
62. Orley J., Kuyken W. (1994) Quality of Life Assessment, International Perspectives, Heidelberg: Springer Verlag.
63. Ottman R. (1996) Gene-environment interaction: definitions and study designs. Preventive Medicine, 25(6), 764-770.
64. Perälä J., Suvisaari J., Saarni S.I., Kuoppasalmi K., Isometsä E., Pirkola S., Partonen T., Tuulio-Henriksson A., Hintikka J., Kieseppä T., Härkänen T., Koskinen S., Lönnqvist J. (2007) Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry, 61(1), 19-28.
65. Rutter M., Moffitt T.E., Caspi A. (2006) Gene-environment interaction and psychopathology: multiple varieties but real effects. Journal of Child Psychology and Psychiatry, 47(3-4): 226-261.
66. Saracco-Alvarez R., Rodríguez-Verdugo S., García-Anaya M., Fresán A. (2010) Premorbid adjustment in schizophrenia and schizoaffective disorder. Psychiatry Research, 165(3), 234-240.
67. Schippers G.M., Dejong C.A.J., Lehert P., Potgieter A., Deckers F., Casselman J., Geerlings P.J. (1997) The Obsessive Compulsive Drinking Scale - translation into Dutch and possible modifications. European Addition Research, 3(3), 116-122.
68. Slade M., Beck A., Bindman J., Thornicroft G., Wright S. (1999) Routine clinical outcome measures for patients with severe mental illness: CANSAS and HoNOS. The British Journal of Psychiatry, 174(May): 404-408.
69. Small N.E., Mohs R.C., Halperin R., Rosen W.G., Masterson C., Kendler K.S., Horvath T.B., Davis K.L. (1984) A study of the reliability of reported premorbid adjustment in schizophrenic patients. Biological Psychiatry, 19(2), 203-211.
70. Stefanis N.C., Hanssen M., Smirnis N.K., Avramopoulos D.A., Evdokimidis I.K., Stefanis C.N., Verdoux H., van Os J. (2002) Evidence that three dimensions of psychosis have a distribution in the general population. Psychological Medicine, 32(2), 347-358.
71. Susser E., Finnerty M., Mojtabai R., Yale S., Conover S., Goetz R., Amador X. (2000) Reliability of the life chart schedule for assessment of the long-term course of schizophrenia. Schizophrenia Research, 42(1): 67-77.
72. Trompenaars F.J., Masthoff E.D., Van Heck G.L., Hodiamont P.P., De Vries J. (2005) Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients. Quality of Life Research, 14(1), 151-160.
73. Van 't Wout M., Aleman A., Kessels R.P., Laroi F., Kahn R.S. (2004) Emotional processing in a non-clinical psychosis-prone sample. Schizophrenia Research, 68(2-3), 271-281.
74. Van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., Van Harten P.N., Valmaggia L., de Hert M., Wiersma D. (2006a) The five-factor model of the Positive and Negative Syndrome Scale I: Confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophrenia Research, 85(1-3), 273-279.
75. Van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., Van Harten P.N., Valmaggia L., de Hert M., Wiersma D. (2006b) The five-factor model of the Positive and Negative Syndrome Scale II: A ten-fold cross-validation of a revised model. Schizophrenia Research, 85(1-3), 280-287.
76. Van Os J., Sham P. (2003) Gene-environment interactions. In The Epidemiology of Schizophrenia Murray R.M., Jones P.B., Susser E. (eds), pp. 235-254, Cambridge: Cambridge University Press.
77. Van Os J., Rutten B.P.F., Paulton R. (2008) Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia Bulletin, 34(6), 1066-1082.
78. Van Os J., Rutten B.P.F., Paulton R. (2010) Gene-environment interactions for searchers: collaborations between epidemiology and molecular genetics. In Advances in Schizophrenia Research Gattaz W.F., Busatto G. (eds), pp. 19-50, New York: Springer Science;+;Business Media.
79. Verdoux H., Sorbara F., Gindre C., Swendsen J.D., van Os J. (2003) Cannabis use and dimensions of psychosis in a nonclinical population of female subjects. Schizophrenia Research, 59(1), 77-84.
80. Verdoux H., van Os J., Sham P., Jones P., Gilvarry K., Murray R.. (1996) Does familiality predispose to both emergence and persistence of psychosis? A follow-up study. The British Journal of Psychiatry, 168(5), 620-626.
81. Verhage F. (1964) Intelligentie en leeftijd: Onderzoek bij Nederlanders van twaalf tot zevenenzeventig jaar, Assen, Van Gorcum (in Dutch).
82. Versmissen D., Janssen I., Myin-Germeys I., Mengelers R., Campo J.A., van Os J., Krabbendam L. (2008) Evidence for a relationship between mentalising deficits and paranoia over the psychosis continuum. Schizophrenia Research, 99(1-3), 103-110.
83. Vollema M.G., Ormel J. (2000) The reliability of the structured interview for schizotypy-revised. Schizophrenia Bulletin, 26(3), 619-629.
84. Vollema M.G., Postma B. (2002) Neurocognitive correlates of schizotypy in first degree relatives of schizophrenia patients. Schizophrenia Bulletin, 28(3), 367-377.
85. Vollema M.G., Sitskoorn M.M., Appels M.C., Kahn R.S. (2002) Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophrenia Research, 54(1-2), 39-45.
86. Wechsler D. (1997) WAIS-III: Wechsler Adult Intelligence Scale (3rd edition) Administration and Scoring Manual, San Antonio, TX, Psychological Corporation.
87. Wing J.K., Babor T., Brugha T., Burke J., Cooper J.E., Giel R., Jablenski A., Regier D., Sartorius N. (1990) SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry, 47(6): 589-593.
88. Wing J.K., Cooper J.E., Sartorius N. (1974) The Measurement and Classification of Psychiatric Symptoms, London: Cambridge University Press.
89. Wohlberg G.W., Kornetsky C. (1973) Substained attention in remitted schizophrenics. Archives of General Psychiatry, 28(4), 533-537.
90. Woody S.R., Steketee G., Chambless D.L. (1995) Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale. Behaviour Research and Therapy, 33(5): 597-605.
91. World Health Organization (WHO). (1990) Composite International Diagnostic Interview (CIDI): a) CIDI-interview (version 1.0), b) CIDI-user manual, c) CIDI-training manual, d) CIDI-computer programs, Geneva, WHO.
92. Zink C.F., Tong Y., Chen Q., Bassett D.S., Stein J.L. Meyer-Lindenberg A. (2008) Know your place: neural processing of social hierarchy in humans. Neuron, 58(2) 273-283.